Andrew Hirsch - Feb 15, 2024 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
President & CEO, Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Feb 15, 2024
Transactions value $
-$51,824
Form type
4
Date filed
2/15/2024, 06:18 PM
Previous filing
Feb 15, 2024
Next filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability -$51.8K -6.56K -3.02% $7.90 211K Feb 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.